跳至主要内容
临床试验/NL-OMON31251
NL-OMON31251招募中不适用

se of a real time continuous glucose monitoring system (RT-CGMS) in type 1 diabetes patients on continuous intraperitoneal insulin infusion (CIPII). A feasibility study. - RT-CGMS in CIPII / IP-SENSOR study

Isala Klinieken0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients on CIPII and treated in the Isala Clinic, Zwolle, The Netherlands.
  • Age >18 years
  • Uncontrolled diabetes mellitus type 1; HbA1c at last measurement (not longer than 6 weeks ago) >7.5% and/or >5 hypoglycaemic events /week as measured by SMBG.

排除标准

  • Failure to obtain informed consent

研究者

发起方
Isala Klinieken

相似试验

se of a real time continuous glucose monitoring... | 临床试验